Disease of Digestive System/Urogenital System/Respiratory System
Conditions
Interventions
Experimental group:SHURUI Single-Port Robotic System
Sponsors
Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine (North Hospital)
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-80 years old, and gender is not limited; 2. Those who are scheduled to undergo any of the following surgeries assisted by the SHURUI Single-Port Robotic System: (1) Gynecological surgeries such as hysterectomy with pelvic lymph node dissection, etc. (2) Urological surgeries such as partial nephrectomy, radical prostatectomy, etc. (3) General surgical procedures such as radical gastrectomy for distal gastric cancer, radical resection of colorectal cancer, hepatectomy/splenectomy, etc. (4) Thoracic surgeries such as segmentectomy/lobectomy, radical resection of esophageal cancer, etc. (5) Others who, as judged by the researcher, have indications for thoracoabdominal endoscopic surgery. 3. Patients fully understand the benefits and risks of this trial, and are willing to participate in this trial and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Have severe heart, lung, brain, liver and kidney diseases, unable to tolerate surgery or anesthesia; 2. Inability to tolerate pneumoperitoneum; 3. Severe anemia, coagulation dysfunction; 4. Pregnant and lactating women; 5. Those with a history of epilepsy or psychiatric illness; 6. Extensive metastasis in the abdomen-pelvic cavity of the tumor; 7. Severe obesity with BMI >= 30 kg/m^2 8. Participated in clinical trials of other drugs or devices within 3 months before surgery; 9. Other conditions deemed unsuitable by the investigator to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Telesurgery non-conversion rate;Clavien-Dindo Grade III or Higher Complication Rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Network Transmission Evaluation;Telesurgery Operation Time;Estimate Blood loss;Blood transfusion rate;Surgeon's satisfaction socre;Fluorescence Imaging Quality Evaluation;Postoperation pain score;The length of hospital stay;Evaluation of postoperative incision;Overall 30-Day Postoperative Complication Rate;30-Day Readmission Rate;30-Day Reoperation Rate;30-Day Mortality Rate;Instrument defects incidence; | — |
Countries
China
Contacts
Public ContactRen Zhao
Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine (North Hospital)
Outcome results
None listed